Insider Transactions in Q3 2025 at Structure Therapeutics Inc. (GPCR)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 18
2025
|
Crespo Blas Coll CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
8,106
-3.6%
|
$56,742
$7.74 P/Share
|
|
Sep 18
2025
|
Ashley Hall Chief Development Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,021
-5.09%
|
$42,147
$7.74 P/Share
|
|
Jul 01
2025
|
Xichen Lin CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
12,846
-5.92%
|
$77,076
$6.84 P/Share
|
|
Jul 01
2025
|
Yingli Ma CHIEF TECHNOLOGY OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
4,470
-3.63%
|
$26,820
$6.84 P/Share
|
|
Jul 01
2025
|
Raymond C Stevens CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
16,050
-1.33%
|
$96,300
$6.84 P/Share
|
|
Jul 01
2025
|
Raymond C Stevens CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
89,697
+6.9%
|
-
|
|
Jul 01
2025
|
Jun Yoon CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
7,089
-0.53%
|
$42,534
$6.84 P/Share
|
|
Jul 01
2025
|
Jun Yoon CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
39,606
+2.9%
|
-
|
|
Jul 01
2025
|
Xichen Lin CHIEF SCIENTIFIC OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
57,078
+20.81%
|
-
|
|
Jul 01
2025
|
Yingli Ma CHIEF TECHNOLOGY OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
24,459
+16.57%
|
-
|
|
Jul 01
2025
|
Crespo Blas Coll CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,434
-0.63%
|
$8,604
$6.84 P/Share
|
|
Jul 01
2025
|
Crespo Blas Coll CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
7,992
+3.41%
|
-
|